SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-034171
Filing Date
2024-03-20
Accepted
2024-03-20 16:12:21
Documents
5
Effectiveness Date
2024-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 2024_s-8_-_annual_share_.htm S-8 105126
2 EX-5.1 trvi-ex5_1.htm EX-5.1 12909
3 EX-23.2 trvi-ex23_2.htm EX-23.2 2594
4 EX-FILING FEES trvi-exfiling_fees.htm EX-FILING FEES 23484
5 GRAPHIC img109914091_0.jpg GRAPHIC 13959
  Complete submission text file 0000950170-24-034171.txt   164540
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278101 | Film No.: 24767913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)